ID: ALA4587355

Max Phase: Preclinical

Molecular Formula: C11H10ClN

Molecular Weight: 191.66

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C#N)=Cc1ccc(C)cc1Cl

Standard InChI:  InChI=1S/C11H10ClN/c1-8-3-4-10(11(12)6-8)5-9(2)7-13/h3-6H,1-2H3

Standard InChI Key:  JAURGPIILHRUCZ-UHFFFAOYSA-N

Associated Targets(Human)

GABA-A receptor; alpha-1/beta-3/gamma-2 1565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 191.66Molecular Weight (Monoisotopic): 191.0502AlogP: 3.58#Rotatable Bonds: 1
Polar Surface Area: 23.79Molecular Species: HBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.87CX LogD: 3.87
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.62Np Likeness Score: -1.03

References

1. Stadler M, Monticelli S, Seidel T, Luger D, Salzer I, Boehm S, Holzer W, Schwarzer C, Urban E, Khom S, Langer T, Pace V, Hering S..  (2018)  Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABAA) Receptor Modulators.,  62  (1): [PMID:30289721] [10.1021/acs.jmedchem.8b00859]

Source